Press "Enter" to skip to content

Zydus Cadila launches affordable oral anti-diabetic tablets in India as drug goes off patent

As the product patent on popular diabetes drug Vildagliptin has expired in India on December 9, some domestic drug firms have launched the generic versions of the drug in the country that are much cheaper than the patented medicine.

Original source:

Also Read:   Mylan working with DCGI to launch new TB drug in India